16 February 2012

BSE, Bulk deals, 16/2/2012

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Deal DateScrip CodeCompanyClient NameDeal Type *QuantityPrice **
16/2/2012531560Aroma EnterprisesJAYANTKUMAR & COMPANY PROP :JAYANTKUMAR MANUBHAI PS500009.00
16/2/2012532989Bafna PharmaGAURAV RAJNI PARIKHB9955947.09
16/2/2012532989Bafna PharmaBHAGWANDAS MAHESH KUMARB12502546.93
16/2/2012532989Bafna PharmaBHAGWANDAS MAHESH KUMARS11506247.10
16/2/2012532989Bafna PharmaNIRAJ RAJNIKANT SHAHS10100046.55
16/2/2012532609Bharati ShipCROSSEAS CAPITAL SERVICES PRIVATE LIMITEDB234119106.13
16/2/2012532609Bharati ShipCROSSEAS CAPITAL SERVICES PRIVATE LIMITEDS234119105.70

16/2/12: FII & DII Turnover (BSE + NSE) (Rs. crore)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



FII & DII Turnover (BSE + NSE)
(Rs. crore)
FIIDII
Trade DateBuySalesNetBuySalesNet
16/2/123,251.563,067.25184.311,383.421,773.74-390.32

NSE, Bulk deals, 16-Feb-2012

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


DateSymbolSecurity NameClient NameBuy / SellQuantity TradedTrade Price /
Wght. Avg.
Price
Remarks
16-Feb-2012BHARTISHIPBharati Shipyard LimitedCROSSEAS CAPITAL SERVICES PVT. LTD.BUY2,34,119105.62-
16-Feb-2012BHARTISHIPBharati Shipyard LimitedCROSSEAS CAPITAL SERVICES PVT. LTD.SELL2,34,119106.20-
16-Feb-2012IVRCLINFRAIVRCL LimitedNORGES BANK A/C NORGES BANK ON ACCOUNT OF THE GOVERNMENT PSELL15,97,03459.28-
16-Feb-2012LITLLanco Infratech LimitedAMBIT SECURITIES BROKING PVT. LTD.BUY122,95,28719.99-
16-Feb-2012LITLLanco Infratech LimitedAMBIT SECURITIES BROKING PVT. LTD.SELL122,14,82020.00-
16-Feb-2012NETWORK18Network18 Media & Inv LtdRAJASTHAN GLOBAL SECURITIES LTDBUY8,26,34741.00-
16-Feb-2012NETWORK18Network18 Media & Inv LtdRUANE CUNNIFF & GOLDFARB INC SUB A/C. ACACIA PARTNERS LPSELL14,63,00042.15-
16-Feb-2012RKDLRavi Kumar DistilleriesNANDLAL VYAPAAR PRIVATE LIMITEDBUY1,67,30216.20-
16-Feb-2012RUSHILRushil Decor LimitedTOWER OVERSEAS LIMITEDBUY88,987177.00-
16-Feb-2012SPYLShekhawati Poly-Yarn Ltd.MADHUKAR SHETHSELL1,50,00026.01-
16-Feb-2012SPYLShekhawati Poly-Yarn Ltd.PARAMOUNT CLUB LLPBUY1,33,95026.00-

16/2/12: Categories Turnover (BSE) (Rs. crore) Clients NRI Proprietary Trade Data

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Categories Turnover (BSE)

(Rs. crore)
ClientsNRIProprietary
Trade DateBuySalesNetBuySalesNetBuySalesNet
16/2/122,439.052,407.6331.431.101.43-0.33920.32911.249.08
15/2/122,557.692,786.88-229.180.972.26-1.291,001.77928.7673.01
14/2/122,273.182,356.80-83.621.161.060.09841.19788.9552.24
Feb , 1226,743.1528,553.67-1,810.5215.1015.51-0.4110,213.809,721.65492.15
Since 1/1/1261,675.6163,748.46-2,072.8532.0335.46-3.4322,210.5421,333.90876.63

MCX IPO

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


INDIA's 1st EXCHANGE IPO MCX Ltd: 22/02/12-24/02/12. Price Band: Rs.860-1032, Lot:6 Sh &multiple of 6. Max app in Ret: 192sh& 1,98,144/-, Rating: 5/5 by Crisil-

FII DERIVATIVES STATISTICS FOR 16-Feb-2012

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


FII DERIVATIVES STATISTICS FOR 16-Feb-2012 
 BUYSELLOPEN INTEREST AT THE END OF THE DAY 
 No. of contractsAmt in CroresNo. of contractsAmt in CroresNo. of contractsAmt in Crores 
INDEX FUTURES755312077.56875162407.1361028316862.35-329.57
INDEX OPTIONS69523818708.9061729416719.31166056645842.581989.59
STOCK FUTURES1457704514.221775085460.39109329233149.33-946.17
STOCK OPTIONS366661090.29382271125.06626951879.05-34.78
      Total679.08

-- 

Not optimistic about outlook for gold: Kunal Shah, Nirmal Bang Commodities (ET)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


In an interview with ET Now, Kunal Shah , Head of Research, Nirmal Bang Commodities, shares his views on the commodities market. Excerpts:

ET Now: Discussing your strategies copper seems to be the first one. What do you think of it as short that you are suggesting?

Kunal Shah: Well, the fundamental of this metal has been bearish since the last couple of months because of increase in liquidity as we have seen prices moving up abruptly. Going forward we believe that the strength in the dollar and the ongoing problem in Europe is definitely going to weigh on copper prices. The Chinese demand outlook is not rosy. We have seen a sharp drop in imports by China from 5 lakh to almost 415,000 tonnes. So, I am of the view that copper prices are going to go down further.

ET Now: Talking of fundamentals crude oil is your next strategy and in the last 24 hours we have seen significant tension building up especially in the Middle East, Iran in particular, and Straits of Hormuz is also coming under military build up and you are suggesting a buy, what is your strategy here?

Kunal Shah: Well, we are first to give a buy because of the ongoing geopolitical tension. The demand and supply of WTI is not as bullish as the prices are portraying. It is just a built up of geopolitical premium which is pushing prices higher. If you look at $101 with the ongoing supply which is coming from US itself, especially from North Dakota, these prices would not be justified at these levels. So, it is just because of the geopolitical tension we see a spike. The maximum upside is till $102 to $150 on NYMEX but this is short lived. The moment this kind of geopolitical concern eases, I think prices will cool off. So, it is more about geopolitical premium rather than the actual demand and supply premium.

ET Now: We were just speaking to some of the global experts and they were of the opinion that till 104-105 - NYMEX has some scope of appreciation. So, beyond this strategy if somebody is looking at going long on crude oil for next couple of weeks, would you suggest that?

Kunal Shah: If you are betting that there is going to be a geopolitical tension, then yes, you should go long in oil. But if you are not, then use this kind of rallies to go short in oil because I am of the view that if there are no geopolitical tensions, then the crude will be the first one to go down. It is just a matter of call more than the demand supply. I think a defence analyst would be in a better position to take a call on this. But I have a view that 104 should be it. I will not be very bullish post that. We have already seen a premium of $10 built in oil, especially in WTI and I am of the view that we are not going to see any geopolitical tension immediately. So, the moment this kind of concerns eases off that is the time you should go short on oil.


ET Now: Talking of precious metals, you also suggest a sell as far as silver is concerned?

Kunal Shah: Silver has run up from 52 to almost 57 on domestic bourses. Similarly, on international bourses, from $28 to almost $34. We have seen no demand pick up. If the silver imports from China has declined, so we are of the view that this liquidity has driven all asset classes across the globe and the moment dollar starts strengthening, you start to move out off from the riskier asset classes.

Since the last few days we are watching a lot of friction in dollar. Dollar has started to strengthen again because of the ongoing concerns about whether there will be a Greek deal or not and we are of the view that this is not the time you should make a fresh investment in silver. If you are having a profit, then you should exit out of it. Riskier traders can go for a short position in silver with a downside expected for the day or two. 55,800 or from the 15 days point of view 55,000 looks very likely.

ET Now: Would you mirror the same strategy on gold as well?

Kunal Shah: If dollar index is strengthening, you should not buy gold. That has been the most common way to track gold. So we are of the view that 1750 on upside should not be taken off by the markets. You are going to see some downside of about $20 to $25 dollar correction in gold. Despite yesterday's rally because of the spark in geopolitical issues, we are still not optimistic about the outlook for gold. We are expecting some downside to take place. So, from the present levels a correction of Rs 150 looks very likely and on COMEX $1700 looks very likely.

Alembic Pharma - conference call transcript :: Edelweiss (pdf link)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Dear Sir/Madam,
Please find enclosed the transcript of the conference call with Alembic Pharma, held on 9th February, 2012.

Sharekhan PDF link: vInvestor's Eye: Update - State Bank of India, Sun Pharmaceutical Industries, Tata Chemicals, CESC; Viewpoint - Eicher Motors; Special - Q3FY2012 Capital Goods & Engineering earnings review

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Investor's Eye
Summary of Contents
STOCK UPDATE
State Bank of India 
Cluster: Apple Green
Recommendation: Buy
Price target: Rs2,400
Current market price: Rs2,129
Price target revised to Rs2,400
Result highlights
  • State Bank of India (SBI)'s Q3FY2012 results were ahead of our estimates as the net profits grew by 15.4% year on year (YoY; 16.1% quarter on quarter [QoQ]) to Rs3,263 crore. This was on account of a strong growth in the net interest income and a decline in the provision expenses.
  • The net interest income (NII) grew by 26.7% YoY (10% QoQ) which was ahead of our estimates. The growth in NII was contributed by a sequential expansion in margins and a strong growth in advances. The domestic net interest margin (NIM) expanded by 32bps QoQ to 4.39%. 
  •  Business growth remained strong as the advances of the bank grew by 19.6% YoY (10% QoQ) led by a strong growth in international as well as agriculture advances. The deposits of the bank registered a growth of 13.9% YoY while the current account savings account (CASA) ratio was at 47.5% (47.6% in Q2FY2012).
  • The non interest income of the bank declined by 35.8% YoY due to the losses (Rs1,090 crore) contributed by treasury, largely from the equity book. The fee income growth also remained subdued, partly contributed by a large base of Q3FY2011.
  • The asset quality of the bank deteriorated on a sequential basis as the gross and net non performing assets (NPAs) increased to 4.61% and 2.22% respectively during the quarter from 4.19% and 2.04% in Q2FY2012. The provision coverage ratio (PCR) of the bank declined to 62.5% from 63.5%. The bank also restructured Rs2,188 crore of advances in Q3FY2012.

Birla Sun Life Monthly Income Fund: Invest ::Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��




The equity exposure is well diversified, with the fund holding around 30 stocks in its portfolio

Mirae Asset India Opportunities Fund: Invest ::Business Line

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Balkrishna Industries - "Robust demand and margin performance leads us to raise estimates" ::LKP

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Capacity expansion mirrors the robust demand outlook
Balkrishna Industries (BKT) reported a robust Q3 FY12 performance above our expectations. Net revenues grew by 54% yoy and 12% qoq, of which 28% yoy came from volumes, while the rest came from growth in realizations and product mix. Volumes for the quarter were at 35,534 MT, up 28% yoy. While there was no price hike taken in the quarter, the YTD price hike was at 16-18%. Sequentially, the volumes grew by 9.5%. The robust volume growth sequentially came on the back of brownfield expansion at its Bhiwadi and Chopanki plants and robust demand for OTR and agri tyres across the globe. The achievable capacity from existing plants now stands at 144,000 MTPA for FY 12E and will move to 156,000 MTPA in FY 13E.  With Bhuj capacity commencing in 3Q FY13, total achievable capacities of BKT are expected to move up to 181,000 MTPA in FY 13E and 231,000 MTPA in FY 14E. With surging demand for OTR tyres, the company has outlayed an additional capacity builtup of 30,000 MTPA of ultra large OTR tyres in FY15E at Rs4bn of capex, which will take the total achievable capacity to 276,000MTPA in FY15E. BKT has an order book of 68,000 MTPA, worth Rs 14 bn which is equivalent to 5.5 months of volume visibility, thus boosting our confidence in the company. BKT seems to be insulated from the macro concerns, especially in Europe, which contributed 48% of total sales, while Americas were at 24%, Asia at 14% and ROW at 14%.
Margins grow to 18.9% in Q3, to move ahead further with better product mix and operating leverage
EBITDA margins grew 50bps sequentially at 18.9% on softening rubber prices and price hikes taken at different times during the year, despite other expenses to sales having increased to 19.1% of sales. RM to sales fell to 59.7% of sales from 62.4% sequentially, which would have fallen even further had the oil derivatives (synthetic rubber) prices become softer. PAT came in 91% yoy and 15% qoq at Rs729mn on robust operational performance and healthy topline growth. Viewing a slight hardening of NR prices due to end of tapping season, BKT has again increased its NR inventory from 3 months to 4-5 months, thus gaining advantage of firming rubber prices in the May quarter. In spite of taking significant price hikes over the year, BKT’s product prices are still at 30% discount to market leaders, thus providing BKT an edge over its competitors in times of slowdown and also allows it to take further price hikes if required. With capacity expansion at Bhuj, operating leverage is bound to come and assist margin growth. Also, the long term view on rubber prices remains soft as rubber prices are expected to move down in FY 13 on increased supply coming from growth in plantation and yield. Furthermore, with additional capacities coming on the high margin OTR side in the next couple of years, the margins are slated to expand by at least 200bps by that period with the Bhuj plant coming up with an in built power plant and rubber mixing plant which would save at least 150 bps of power and transportation costs. With robust Q3 FY13 margins and expectation of improvement going forward, we have raised our margin estimates for FY 12E/13E to 18.6%/19.2% respectively.
Outlook and valuation
In line with continued visibility on volumes and margins coupled with above expected results, we are increasing our estimates for BKT. At CMP, the stock trades at 6.3x times its FY 13E EPS of Rs 39. We now value the company at 7.5x times on FY 13 earnings, while increasing our target price to Rs 292 and maintain BUY rating on the stock.

Marico - Leap into high growth category; event update; Buy :: Edelweiss (pdf link)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Marico (MRCO IN, INR 165, Buy)
Marico announced 100% acquisition of Paras Personal Care Business (sales for FY12E: INR1.5bn) for an undisclosed consideration. This would give Marico access to brands like Set Wet, Livon and Zatak, ranked amongst top three in respective categories. Acquisition of this business is likely to further reduce Marico’s dependence on edibles oils and hair oils besides giving it an opportunity to participate in the rapidly growing categories in India. We reiterate ‘BUY’ on the stock.

Result Update: , Eicher Motors Ltd, Sun Pharma, Motherson Sumi Systems Ltd, State Bank of India :: Emkay


Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Click in link to read report: Result Update



Eicher Motors Ltd
Reco: HOLD
CMP: Rs 1,705
Target Price: Rs 1,915
Mixed bag, Downgrade to HOLD
·      EBIDTA at 1.5bn (4% below est). APAT at Rs 854mn (in line). CV business surprised positively, while two wheeler performance was below est.
·      Waiting list for two wheelers continues despite capacity increase. Strong CV performance will be driven by expansion in HD
·      Fine tune CY12 est. by -2% to Rs 137.8. Introduce CY13 with EPS of Rs 161. See downside risk to vol. est. due to macro environment/capacity constraints
·      Downgrade to HOLD with a TP of Rs 1,915 (current business value – Rs 1,762, NPV of engine business – Rs 153). Key triggers – faster capacity addition of two wheelers


Sun Pharma
Reco: ACCUMULATE
CMP: Rs 552
Target Price: Rs 586
Strong Performance - Maintain Accumulate
·      Sun Pharma’s Q3FY12 results - Revenues at Rs21bn (up 34% YoY), EBITDA at Rs9.6bn (up 119% YoY) and RPAT at Rs6.6bn (up 91% YoY)
·      Strong performance was led by 63% growth in US which was driven by ramp-up in market share of recently launched products, increase in selling prices of select products in Taro and INR dep. Domestic biz grew 17%
·      Going forward in FY13E, growth will be driven by Para-IV launch of Lexapro, Plavix, Eloxatin and Stalevo in US and continued momentum in domestic biz
·      With strong traction from US market and a stable domestic business – we maintain Accumulate rating with a revised target price of Rs586 at 21x FY13E EPS of Rs28


Motherson Sumi Systems Ltd
Reco: ACCUMULATE
CMP: Rs 174
Target Price: Rs 210
In line, Retain ACCUMULATE
·      EBIDTA at Rs 2.6bn was in line (est. Rs 2.5bn). APAT at Rs 1.2bn was above est. of Rs 885mn due to lower tax rate. SMR reports 150bps QoQ margins expansion with higher utilization
·      Peguform reports Sales/Adj. EBITDA/APAT of Rs11.5bn/Rs 43mn/ Rs -156mn for 38 days. Peguform to be EPS accretive but not assigning value due to limited information
·      Concerns with Debt overdone. Net Debt (ex Peguform) is Rs 16bn (marginally up QoQ).  Of the total gross debt of Rs 29bn of Peguform, debt attributable to MSSL is only Rs 11bn
·      Retain ACCUMULATE with a TP of Rs 210.  SMR margins to further improve with increase in utilization. Major benefit visible from 2QFY13


State Bank of India
Reco: HOLD
CMP: Rs 2,129
Target Price: Rs 1,950
Slippages remain higher; capital infusion inadequate
·      SBI Q3FY12 – NII at Rs114bn ahead of estimates aided by higher loan growth and strong NIM at 4.1%. However, with lower other inc, PAT at Rs32.6bn came in line with our est
·      Asset quality continues to disappoint with gross slippages at Rs81bn (3.6% ann). Further, despite equity infusion, Net NPL / networth would stand at high 20%+ for FY12
·      Loan growth at 7% qoq came in as a surprise. With 3% qoq growth in deposits, LDR inched 330bps qoq to 85%. Mgmt guided for 16% yoy loan growth for FY12
·      Capital infusion + plough back of PAT would raise tier I CAR to 9%.  Also, with lower accretion in net slippages, pressure on asset quality to ease. Upgrade to Hold with PT of 1,950